Post-discharge health-related quality of life, cognitive function, disability, risk of post-traumatic stress disorder, and depression amongst the survivors of venovenous extracorporeal membrane oxygenation (VV-ECMO) during the COVID-19 pandemic: a nested cohort study protocol

Eunicia Ursu,Ana Mikolic,Sonny Thiara,Noah D Silverberg,Denise Foster,William Panenka,Nishtha Parag,Mypinder S Sekhon,Donald E.G. Griesdale

DOI: https://doi.org/10.1101/2024.08.22.24312450

2024-08-26

Abstract:Veno-venous extra-corporeal membrane oxygenation (VV ECMO) is a form of mechanical respiratory support for critically ill patients with severe acute respiratory distress syndrome (ARDS). Using a large intravenous line in a closed circuit, blood is removed from the patient and passed through a hollow fiber membrane where oxygen is added and carbon dioxide is removed. The oxygenated blood is then reinfused into the patient. Overt neurologic injury (ischemic stroke or intracerebral hemorrhage) occurs in approximately 20% of patients who receive VV ECMO. However, it is unclear if there is additional unrecognized neurologic disability amongst patients who survive VV ECMO. As such, we will perform a cohort study nested within our existing prospective study of patients who underwent VV ECMO during the COVID 19 pandemic. We expect to ascertain long-term patient reported and performance-based outcomes in greater than 60% of survivors of VV-ECMO. This study will provide important patient-centric long-term outcomes in contrast to the majority of existing studies of patients on VV-ECMO which focus solely on short-term survival. We will include 39 patients who survived VV-ECMO and ascertain patient reported and performance-based outcomes through phone interviews. We will measure: i) Health Related Quality of Life (HRQoL) using the EQ 5D 5L, ii) cognitive function using the T-MoCA Short, iii) disability using the World Health Organization Disability Assessment Scale (WHODAS) 2.0, iv) post traumatic stress disorder (PTSD) using the Impact of Event Scale 6 (IES 6), and v) depression using the Patient Health Questionnaire 9 (PHQ-9). The results from the analysis of the study data will be disseminated through presentation of a scientific abstract at international conference, and submission of a manuscript in a peer-reviewed critical care medicine journal. The study ethical approval has been obtained from the University of British Columbia (UBC) Clinical Research Ethics Board (REB)(H21 00033) and the Vancouver Coastal Health Research Institute (V21 00033).

Intensive Care and Critical Care Medicine

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the long - term health - related quality of life, cognitive function, disability status, post - traumatic stress disorder (PTSD) and the risk of depression among survivors treated with veno - venous extracorporeal membrane oxygenation (VV - ECMO) during the COVID - 19 pandemic. Specifically, the study aims to evaluate the long - term outcomes of these patients in the following aspects:

1. **Health - related quality of life (HRQoL)**: Measured using the EQ - 5D - 5L scale.
2. **Cognitive function**: Measured using the T - MoCA Short scale.
3. **Disability status**: Measured using the World Health Organization Disability Assessment Schedule (WHODAS 2.0).
4. **Post - traumatic stress disorder (PTSD)**: Measured using the Impact of Event Scale - 6 (IES - 6).
5. **Depressive symptoms**: Measured using the Patient Health Questionnaire - 9 (PHQ - 9).

The research background points out that although VV - ECMO is an effective method of mechanical respiratory support for treating patients with severe acute respiratory distress syndrome (ARDS), approximately 20% of patients receiving VV - ECMO treatment will experience significant neurological damage (such as ischemic stroke or intracranial hemorrhage). However, it is currently unclear whether these patients also have unrecognized neurological disabilities. Therefore, this nested cohort study aims to fill this knowledge gap and provide important patient - centered long - term outcome data, not just short - term survival rates.